I. Beria

发表

Novel phenyl nitrogen mustard and half-mustard derivatives of distamycin A

Laura Capolongo, Nicola Mongelli, Enzio Ragg, 1997 .

Phenyl sulfur mustard derivatives of distamycin A.

P. Cozzi, C. Geroni, E. Ragg, 2000, Bioorganic & medicinal chemistry letters.

Abstract 822: Thienoindoles, a novel class of DNA minor groove alkylating agents highly suited for the generation of novel antibody drug conjugates (ADCs)

A. Isacchi, E. Felder, M. Ciomei, 2014 .

Abstract 734: Thienoindoles: New highly promising agents for antibody-drug conjugates generation

A. Isacchi, E. Felder, M. Ciomei, 2018, Experimental and Molecular Therapeutics.

Role of glutathione transferases in the mechanism of brostallicin activation.

M. Broggini, A. Caccuri, G. Federici, 2010, Biochemistry.

4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors.

F. Fiorentini, M. Brasca, F. Roletto, 2010, Bioorganic & medicinal chemistry letters.

Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.

P. Cappella, F. Sola, R. Alzani, 2010, Anticancer research.

NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor.

F. Fiorentini, M. Brasca, E. Pesenti, 2011, Bioorganic & Medicinal Chemistry Letters.

434 POSTER Antitumoral activity of pyrazoloquinazoline derivatives as potent oral Plk-1 specific inhibitors

M. Brasca, E. Pesenti, M. Rocchetti, 2008 .

Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors.

D. Ballinari, V. Croci, D. Volpi, 2010, Journal of medicinal chemistry.

Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies.

J. Hartley, P. Baraldi, R. Romagnoli, 2004, Bioorganic & medicinal chemistry.

Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.

R Gambari, R. Gambari, N. Bianchi, 2000, Journal of medicinal chemistry.

Novel phenyl nitrogen mustard and half-mustard derivatives of amidino-modified distamycin

Laura Capolongo, Nicola Mongelli, Paolo Cozzi, 1997 .

Cytotoxic α-Halogenoacrylic Derivatives of Distamycin A and Congeners

S. Marchini, P. Baraldi, R. Romagnoli, 2004 .

NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies

A. Isacchi, E. Felder, D. Ballinari, 2012, Molecular Cancer Therapeutics.

5-(2-amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors.

D. Ballinari, F. Fiorentini, M. Brasca, 2012, Bioorganic & medicinal chemistry letters.

Preclinical Development NMSP 937 , an Orally Available , Speci fi c Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies

A. Isacchi, E. Felder, D. Ballinari, 2012 .

Structure-activity relationship of novel tallimustine derivatives: synthesis and antitumor activity

G. Spalluto, B. Cacciari, P. Baraldi, 1996 .

Synthesis and growth inhibition activity of alpha-bromoacrylic heterocyclic and benzoheterocyclic derivatives of distamycin A modified on the amidino moiety.

Roberto Gambari, Paolo Cozzi, Nicoletta Bianchi, 2003, Bioorganic & medicinal chemistry.

Cytotoxic α-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety

P. Cozzi, C. Geroni, M. Caldarelli, 2000 .

Cytotoxic halogenoacrylic derivatives of distamycin A.

P. Cozzi, C. Geroni, M. Caldarelli, 2000, Bioorganic & medicinal chemistry letters.

Sequence-specific DNA alkylation of novel tallimustine derivatives.

M. Broggini, M. D’Incalci, S. Marchini, 1998, Anti-cancer drug design.